BAYZF (BAYZF) Stock Price & Analysis
BAYZF (BAYZF) rose 0.66% to USD 41.27 as of June 10, 2026 at 02:21 UTC, according to Nexqual real-time market data.
BAYZF last closed at USD 41; the session ranged USD 41.19–41.27 on volume of 500 shares. Market capitalization is $40.54B, with a 52-week range of USD 29.16–58.33 (OQX). Source: Nexqual, June 10, 2026 at 02:21 UTC.
Key Statistics (as of June 10, 2026 at 02:21 UTC)
| Price | USD 41.27 |
|---|---|
| Change | ▲ 0.66% (up) |
| Previous Close | USD 41 |
| Open | USD 41.19 |
| Day Range | USD 41.19 – 41.27 |
| 52-Week Range | USD 29.16 – 58.33 |
| Volume | 500 shares |
| Market Cap | $40.54B |
| Exchange | OQX |
Technical Analysis (BAYZF)
Nexqual's technical model rates BAYZF "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.17 (neutral) |
| vs SMA50 | Below (USD 44.79) |
| MACD | -1.15 (negative) |
Analyst Ratings (BAYZF)
Wall Street analysts rate BAYZF "None", per Nexqual as of June 10, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (BAYZF)
| Next Earnings Date | 2026-08-04 |
|---|---|
| Revenue Estimate | $10.75B |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financials & Fundamentals (BAYZF)
| Total Revenue | $45.24B |
|---|---|
| Revenue Growth (YoY) | -2.40% |
| Gross Margin | +59.92% |
| Operating Margin | +26.32% |
| Profit Margin | -4.76% |
| ROE | -6.93% |
| Debt / Equity | 134.27 |
| Current Ratio | 1.06 |
| Total Cash | $6.66B |
| Total Debt | $38.89B |
| Free Cash Flow | $7.31B |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financial Health Score (BAYZF)
Nexqual rates BAYZF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:21 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 60%, operating 26% |
| Balance Sheet | Mixed — $6.66B cash vs $38.9B debt |
| Cash Flow | Strong — FCF $7.31B, 16% margin |
| Efficiency | Critical — ROE -7%, ROA 3.6% |
Ownership (BAYZF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +58.39% |
| Shares Outstanding | 982.42M |
| Float | 982.42M |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Leadership (BAYZF)
BAYZF is led by William N. Anderson (age 59), Chairman of the Management Board & CEO, per Nexqual as of June 10, 2026 at 02:21 UTC.
| Chairman of the Management Board & CEO | William N. Anderson (age 59) |
|---|---|
| Chief Talent Officer, Labor Director & Member of Management Board | Heike Prinz (age 61) |
| CFO & Member of Management Board | Judith Hartmann (age 56) |
| Member of Management Board, Head of the Crop Science Division & President of Crop Science Division | Rodrigo Santos (age 52) |
| Member of Management Board & President of Consumer Health Division | Julio Triana (age 60) |
Major Backers & Investors (BAYZF)
Notable institutional backers of BAYZF include Dodge & Cox Funds-Dodge & Cox International Stock Fund, NEW PERSPECTIVE FUND, HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark International Fund, according to Nexqual as of June 10, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Dodge & Cox Funds-Dodge & Cox International Stock Fund | 2.73% |
| NEW PERSPECTIVE FUND | 0.76% |
| HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark International Fund | 0.56% |
| Fidelity | 0.37% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.42% |
| BlackRock | 1.06% |
| Dimensional Fund Advisors | 0.3% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BFFAF | BASF SE | USD 61.5 | ▲ 7.12% |
| DSKYF | Daiichi Sankyo Co., Ltd. | USD 14.96 | ▼ 2.09% |
| NVSEF | Novartis AG | USD 148.8 | ▲ 2.71% |
| SNYNF | Sanofi | USD 88.5 | ▲ 0.9% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:21 UTC. This page is informational and not investment advice.